"It was particularly interesting to learn what lasting impacts a GLP-1 medication may have on consumers they continue to try to maintain those healthy eating habits even as the 'food noise' returns." "As a result of the study, we have identified key implications for brands and retailers regarding product prioritizations and how we can best convey product benefits to support weight loss journeys, both during and post GLP-1 therapy," said Jami McDermid, president, CROSSMARK Sales Agency, a division of Acosta Group
Isolation of mitogenically active C-terminal truncated pentapeptide of osteogenic growth peptide from human plasma and culture medium of murine osteoblastic cells
This deficiency is common, affecting approximately 6% of people under the age of 60 and 20% of people over the age of 60
GLP-1 receptors are not limited to the gut and pancreas
Any decision about managing endometriosis belongs with a qualified provider
Personalized GLP-1 Selection: Finding Your Best Option for Menopause Weight Loss PlexusDx offers multiple semaglutide delivery options to match your lifestyle and menopause symptom profile